Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NADMED
Helsinki, Uusimaa, Finlandnadmed.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
NADMED has developed the first CE-marked diagnostic kits capable of accurately measuring all four bodily forms of vitamin B3 metabolites (NADs) and glutathiones directly from fresh blood within hours. The technology has been validated against mass spectrometry and provides higher throughput at lower cost. It supports clinical laboratories, research institutions, CROs, pharmaceutical companies in biomarker studies for drug development and personalized medicine. The company serves clients in over 27 countries including major pharma/biotech partners such as Synlab, Newcastle University, NIH, Clene Nanomedicine.
- Therapeutic areas
- Metabolic DisordersOncologyOtherCardiovascularNeurology
- Modalities
- Device (diagnostic kit)Laboratory service (biomarker measurement)
- Industry
- Metabolite Diagnostics
02
Partnerships
SynlabNewcastle UniversityNIHClene NanomedicineTruDiagnostic
Beyond the preview
Go deeper on NADMED.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NADMED.